2008
DOI: 10.1186/1755-8794-1-20
|View full text |Cite
|
Sign up to set email alerts
|

Generation of a non-small cell lung cancer transcriptome microarray

Abstract: Background: Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality worldwide. At present no reliable biomarkers are available to guide the management of this condition. Microarray technology may allow appropriate biomarkers to be identified but present platforms are lacking disease focus and are thus likely to miss potentially vital information contained in patient tissue samples.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
24
0

Year Published

2008
2008
2014
2014

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 19 publications
(25 citation statements)
references
References 39 publications
(34 reference statements)
1
24
0
Order By: Relevance
“…This possibility cannot be excluded on the basis of the experimental design and the controls included here. Because the number of cells recovered by flow cytometry was relatively small (ϳ5 ϫ 10 5 ), we used linear enzymatic amplification (6,25,30,33) to generate sufficient RNA for microarray hybridization. Before and after RNA amplification, portions of the same RNA samples as those analyzed with microarrays were used as the template for RT-PCR.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This possibility cannot be excluded on the basis of the experimental design and the controls included here. Because the number of cells recovered by flow cytometry was relatively small (ϳ5 ϫ 10 5 ), we used linear enzymatic amplification (6,25,30,33) to generate sufficient RNA for microarray hybridization. Before and after RNA amplification, portions of the same RNA samples as those analyzed with microarrays were used as the template for RT-PCR.…”
Section: Discussionmentioning
confidence: 99%
“…HCT-8 cells seeded in T25 flasks, or 96-well plates were infected with C. parvum oocysts at a 1:1, 1:2, 1:4, or 1:50 oocyst/host cell ratio and incubated for 6,19,24,30,43,48,72, and 88 h as described above. Monolayers were released as described above, washed three times with PBS, and incubated with fluorescein-labeled lectins (Vector Laboratories, Burlingame, CA) at 37°C for 30 min (10) before or after the permeabilization of cell membranes with 100% methanol for 15 min.…”
Section: Methodsmentioning
confidence: 99%
“…Total RNA was amplified using the NuGEN WT-Ovation FFPE System (NuGEN, San Carlos, CA) and hybridized to the Almac Breast Cancer DSA (Affymetrix, Santa Clara, CA) as described previously (19,20). …”
Section: Methodsmentioning
confidence: 99%
“…Almac have developed a range of high density Disease SpeciWc MicroArrays (DSAs™) manufactured on the gold standard AVymetrix platform, which capture as completely as possible all transcripts transcribed in a speciWc disease setting such as breast, colorectal or nonsmall cell lung cancer. The actual content of the DSA is derived using a combination of high throughput 3Ј-based sequencing, data mining and expression analysis (Tanney et al 2008) (Fig. 4).…”
Section: Dna Microarray Analysis Of Ffpe Samplesmentioning
confidence: 99%